Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.05 – $0.30
43% from low
Exchange
OTC Link
CS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.1M | $2.2M | $2.5M | $2.7M | $3.0M | $2.7M | $3.3M | $3.1M |
| Cost of revenue | $967.6K | $1.1M | $1.3M | $619.9K | $821.6K | $636.3K | $1.7M | $753.4K |
| Gross profit | $1.2M | $1.1M | $1.2M | $2.0M | $2.2M | $2.0M | $1.6M | $2.3M |
| Gross margin | 54.4% | 49.2% | 46.6% | 76.7% | 72.8% | 76.2% | 49.1% | 75.3% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$7.6K | −$103.3K | $78.2K | $212.0K | −$54.4K | −$239.2K | −$628.5K | −$107.9K |
| EBITDA | $7.5K | −$366.7K | $99.3K | $274.5K | −$7.1K | −$197.7K | −$996.0K | −$59.2K |
| Net income | −$15.3K | −$358.0K | $141.1K | $201.7K | −$97.6K | −$218.5K | −$920.2K | −$138.6K |
| Net margin | -0.7% | -16.4% | 5.6% | 7.6% | -3.2% | -8.2% | -27.6% | -4.5% |
| EPS (diluted) | -0.00 | -0.01 | 0.01 | 0.01 | -0.00 | -0.01 | -0.02 | -0.00 |
Annual figures · source: Financial Modeling Prep
KELYNIAM GLOBAL INC
No one on the platform currently holds KLYG.
No tracked institution reports a position in KLYG as of their last filing.
No one on the platform has traded KLYG yet.
| -50.00% |
| $3M |
| — |
| IGEXIndo Global Exchange(s) PTE, Ltd. | $0.00 | +0.00% | $2M | — |
| MSIUMedical Supply International USA, Inc. | $0.00 | +0.00% | $20405 | — |
Source: Financial Modeling Prep · peers by sector/industry
Click to see transaction details on SEC.gov. Form 4s cover trades by officers, directors, and 10%+ owners, due within 2 business days of the trade.
Trading at 1.6× sales vs its 1.0× historical median P/S.
Fair value ≈ $0.10 · price $0.16 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.
Kelyniam Global (OTCID: $KLYG ) presents its custom cranial and craniofacial implants delivered within 24 to 48 hours at the Life Sciences Virtual Investor Forum on June 25 at 11:30 AM ET. Kelyniam Global, Inc. (OTCID: KLYG) takes the stage at the Life Sciences Virtual Investor Forum, co-hosted by Virtual Investor Conferences and Zacks Small Cap Research, at 11:30 AM ET on Thursday, June 25, 2026. The Life Sciences Virtual Investor Forum is a B2i Digital Featured Conference. For more details, please visit: https://b2idigital.com/vic-june-25th-life-sciences-virtual-investor-forum To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5389342/kelyniam-global-inc-otcid-klyg?utm_source=b2i&utm_medium=marketing&utm_campaign=0624LifeSciencesForumVIC Request a one-on-one meeting: https://app.axleaccess.com/public/events/636943bb-55cb-4a39-81b5-f658175de392?token=7b91921e-7b44-4da7-be93-ea5c37a5ed76 Terrance Kurtenbach, CFO, presents for Kelyniam. He joined the company in 2020 after a career with Deloitte, where he served as a US Global Managing Partner in Life Sciences and Healthcare Tax. Kelyniam is an industry leader in delivering custom cranial and craniofacial implants within 24 to 48 hours of surgeon approval for rush and expedited cases, helping reduce hospital length of stay and the associated risk of infection. Designed and manufactured in the United States, its implants are built to high standards of precision, safety, and reliability. Learn more at https://kelyniam.com/. Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com. Discover more emerging growth Featured Companies, industry-leading Featured Experts, and upcoming Featured Conferences at https://b2idigital.com. B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.
View on StockTwits ↗$INND you're going to lose here or been losing since all of your post, forget matty until r/s. look at this one $KLYG do you see the difference?
View on StockTwits ↗$KLYG Is anyone buying this? Would love to see more consistent revenue growth and profitability.
View on StockTwits ↗$KLYG A RECORD YEAR FOR KLYG! "Ross Bjella, Kelyniam's CEO, announced today a number of important updates ahead of the recurring announcements associated with the Company's traditional March corporate disclosures: Kelyniam Global will announce calendar year '24 record revenues in excess of $3.3 million resulting in growth of at least 25%. The Company will report an increased operating income of at least at half million dollars ($500,000) over calendar year 2023. Further details on operations results will be reported later in mid-March, The Company completed an exhaustive review of legacy and Covid-related costs, assets and obligations and will report several matters outside of continuing operations in its annual financial statements. These matters, the majority of which are non-cash, represent a corporate reset and involve obsolete inventory, disposition of assets, satisfaction of compensatory obligations and a comprehensive review of the balance sheet for stranded assets and obligations. The results of this exercise will be reported as Restructuring Costs and Non-cash Compensation. The Company has been notified by its Broker-Dealer marketplace, OTCIQ, that it will be changing the requirements for the exchange where Kelyniam shares are traded. The Company plans to take the necessary steps to qualify for and move to the new OTCID Basic Market in 2025. The Company is contemplating a reverse stock split to occur after the annual shareholders meeting in late June 2025. The Company is undertaking this effort to provide our shareholders with additional depository and liquidity opportunities not currently available due to the current share price offering of less than $1. The Company has not yet decided the extent of reverse split to be recommended, if at all, to the shareholders for approval."
View on StockTwits ↗News Article $KLYG Kelyniam Global Releases Q3 Financials, Strong Performance Continues https://marketwirenews.com/news-releases/kelyniam-global-releases-q3-financials-strong-perfor-5214058185229198.html $KLYG
View on StockTwits ↗I found you a MACD Bearish Reversal Divergence on the daily chart of Kelyniam Global Inc. $KLYG #KLYG #macd #divergence #pink #tradingsignals #technicalanalysis
View on StockTwits ↗$KLYG News Kelyniam Global Releases Strong Q2 Financials https://marketwirenews.com/news-releases/kelyniam-global-releases-strong-q2-financials-7319925456914250.html $KLYG
View on StockTwits ↗$KLYG Kelyniam Global Releases 3rd Quarter 2023 Financials
View on StockTwits ↗$KLYG Kelyniam Global Releases 2nd Quarter 2023 Financials https://www.stocktitan.net/news/KLYG/kelyniam-global-releases-2nd-quarter-2023-pd2rcthycrlx.html
View on StockTwits ↗Recent $TICKER stream from stocktwits.com — refreshed every 5 minutes. Sentiment tags are self-reported by posters. Not investment advice.